Clinical trials
Completed Phase 4 trials in Slovakia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 3 |
| 2006 | 10 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 8 |
| 2011 | 11 |
| 2012 | 11 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 10 |
| Novartis Pharmaceuticals | 10 |
| Pfizer | 9 |
| Hoffmann-La Roche | 8 |
| Astellas Pharma Inc | 5 |
| AstraZeneca | 5 |
| Boehringer Ingelheim | 5 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 5 |
| Eli Lilly and Company | 3 |
| Novartis | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 13 |
| Arthritis, Rheumatoid | 7 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Diabetes Mellitus | 5 |
| Parkinson Disease | 5 |
| Atrial Fibrillation | 4 |
| Cardiovascular Diseases | 4 |
| Urinary Bladder, Overactive | 4 |
| Asthma | 3 |
| Coronary Artery Disease | 3 |
Trials
Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.